Shandong, China

Yue Yu

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Qilu Pharmaceutical Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yue Yu. Retrieved from https://idiyas.com/inventor/yue-yu-rz84qogi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yue Yu - Innovator in Pharmaceutical Composition

Introduction

Yue Yu is a notable inventor based in Shandong, China. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance therapeutic efficacy.

Latest Patents

Yue Yu holds a patent for a composition comprising aflibercept and a variant thereof. This patent describes a composition where the variant is a truncation variant with a truncated VEGF binding portion of aflibercept. The content of the truncation variant is specified to be less than or equal to about 20% by mass percentage. Additionally, the patent includes a pharmaceutical formulation comprising this composition, a method for detecting the variant, and its use in quality inspection or quality control of aflibercept-containing products. She has 1 patent to her name.

Career Highlights

Yue Yu is associated with Qilu Pharmaceutical Co., Ltd., where she has been instrumental in advancing pharmaceutical research and development. Her work focuses on creating effective therapeutic solutions that address various medical needs.

Collaborations

Yue collaborates with esteemed colleagues, including Guijiang Wang and Jiulin Wang, to further enhance the impact of her research and innovations.

Conclusion

Yue Yu's contributions to pharmaceutical compositions demonstrate her commitment to innovation in the healthcare sector. Her work continues to influence the development of effective treatments and quality control measures in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…